simvastatin has been researched along with Muscular Dystrophy, Duchenne in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Dulak, J; Kaziród, K; Mucha, O; Podkalicka, P; Samborowska, E; Łoboda, A | 1 |
| Aartsma-Rus, A; Verhaart, I; Wells, D | 1 |
| Adams, ME; Bible, KL; Froehner, SC; Kim, MJ; Whitehead, NP | 2 |
| Bertil-Froidevaux, E; Bordier, F; Bourg, N; Daniele, N; Georger, C; Guerchet, N; Israeli, D; Jaber, A; Lostal, W; Richard, I; Tanniou, G; Vu Hong, A | 1 |
| Aartsma-Rus, A; Bull, D; Cappellari, O; Hildyard, JCW; Nnorom, S; Plomp, JJ; Tanganyika-de Winter, CL; Verhaart, IEC; Wells, DJ; Wells, KE | 1 |
| Adams, ME; Bible, KL; Froehner, SC; Kim, MJ; Regnier, M; Whitehead, NP | 1 |
7 other study(ies) available for simvastatin and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy.
Topics: Animals; Disease Models, Animal; Dystrophin; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Simvastatin | 2021 |
Author's Response to: Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020.
Topics: Animals; Disease Models, Animal; Mice; Muscles; Muscular Dystrophy, Duchenne; Simvastatin | 2021 |
Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020.
Topics: Animals; Disease Models, Animal; Mice; Muscles; Muscular Dystrophy, Duchenne; Simvastatin | 2021 |
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.
Topics: Animals; Disease Models, Animal; Genetic Therapy; Male; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Simvastatin | 2022 |
Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy.
Topics: Animals; Disease Models, Animal; Fibrosis; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Simvastatin | 2021 |
Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy.
Topics: Animals; Autonomic Nervous System; Calcium-Binding Proteins; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart; Heart Rate; Male; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocytes, Cardiac; Phosphorylation; Recovery of Function; Simvastatin; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |
A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Topics: Animals; Creatine Kinase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Inbred mdx; Multienzyme Complexes; Muscle Fibers, Skeletal; Muscle Strength; Muscular Dystrophy, Duchenne; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Simvastatin | 2015 |